Literature DB >> 11758677

An historical overview of Fabry disease.

H Fabry.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11758677     DOI： 10.1023/a:1012443001449

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  4 in total

1.  A Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometric Assay for the Quantification of Fabry Disease Biomarker Globotriaosylceramide (GB3) in Fabry Model Mouse.

Authors:  Seok-Ho Shin; Min-Ho Park; Jin-Ju Byeon; Byeong Ill Lee; Yuri Park; Ah-Ra Ko; Mi-Ran Seong; Soyeon Lee; Mi Ra Kim; Jinwook Seo; Myung Eun Jung; Dong-Kyu Jin; Young G Shin
Journal:  Pharmaceutics       Date:  2018-06-07       Impact factor: 6.321

2.  Global research on Fabry's disease: Demands for a rare disease.

Authors:  Doris Klingelhöfer; Markus Braun; Rebekka K Seeger-Zybok; David Quarcoo; Dörthe Brüggmann; David A Groneberg
Journal:  Mol Genet Genomic Med       Date:  2020-02-07       Impact factor: 2.183

3.  Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease.

Authors:  Fernando C Fervenza; Roser Torra; David G Warnock
Journal:  Biologics       Date:  2008-12

4.  A Case of Cerebral Aneurysmal Subarachnoid Hemorrhage in Fabry's Disease.

Authors:  Youn Hyuk Chang; Sung-Kyun Hwang
Journal:  J Korean Neurosurg Soc       Date:  2013-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.